Results 1 to 10 of about 200,495 (117)
Effect of the Concomitant Use of Subcutaneous Basal Insulin and Intravenous Insulin Infusion in the Treatment of Severe Hyperglycemic Patients [PDF]
Background No consensus exists regarding the early use of subcutaneous (SC) basal insulin facilitating the transition from continuous intravenous insulin infusion (CIII) to multiple SC insulin injections in patients with severe hyperglycemia other than ...
Yejee Lim +12 more
doaj +1 more source
Background. Basal-bolus insulin therapy is the most widely accepted method of glycemic control in non-critically ill patients with T2DM. In this regimen glargine U100 is the most commonly used basal insulin.
Asis Mitra, Saswati Ray, Sushma Jayan
doaj +1 more source
Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
The advances in recombinant DNA technology have led to an improvement in the properties of currently available long-acting insulin analogs. Insulin degludec, a new generation ultra-long-acting basal insulin, currently in phase 3 clinical trials, has a ...
Sami N. Nasrallah, L. Raymond Reynolds
doaj +2 more sources
AimsTo examine the glycaemic variability and safety of basal and premixed insulin by using continuous glucose monitoring (CGM) systems.Methods393 patients with type 2 diabetes mellitus (T2DM) treated with basal or premixed insulin for more than 3 months ...
Huiying Wang +9 more
doaj +1 more source
基于多中心前瞻性真实世界数据的基础胰岛素和预混合胰岛素对2型糖尿病患者血糖控制的影响研究
Background To investigate the different efficacies of glycemic control between basal and premixed insulin in participants with type 2 diabetes (T2DM) when non‐insulin medications fail to reach treatment targets.
Ying Peng +15 more
doaj +1 more source
Effect of Insulin Plant (Costus igneus) Leaf Powder in Broiler Chickens (Gallus galluus domisticus)
This experiment was conducted to evaluate the effects of insulin plant leaf powder in broiler chickens. One hundred (100) chicks of the same age and random sexes were purchased from the local agrivet supplier and were used in the study.
Carla M Bagunoc +2 more
doaj +1 more source
Insulin degludec/insulin aspart (IDegAsp) is a fixed-ratio co-formulation of insulin degludec (IDeg), which provides long-lasting basal insulin coverage, and insulin aspart (IAsp), which targets post-prandial glucose. This expert panel aimed to provide a
Tevfik Demir +5 more
doaj +1 more source
Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective Review [PDF]
Dulaglutide, a weekly injectable glucagon-like peptide-1 receptor agonist, has demonstrated effectiveness when combined with basal insulin. We examined whether the efficacy of dulaglutide is comparable to that of prandial insulin in kidney transplant (KT)
Hwi Seung Kim +4 more
doaj +1 more source
Degludec insulin: A novel basal insulin
This paper reviews a novel insulin analogue, degludec, which has the potential to emerge as an ideal basal insulin. It reviews the limitations of existing basal insulin and analogues, and highlights the need for a newer molecule.
Sanjay Kalra +3 more
doaj +1 more source

